本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

22.06
-0.3800-1.69%
成交量:14.29萬
成交額:320.13萬
市值:24.99億
市盈率:-6.38
高:22.97
開:22.80
低:22.00
收:22.44
52周最高:34.29
52周最低:13.18
股本:1.13億
流通股本:1.01億
量比:0.92
換手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):-3.4579
每股收益(LYR):-3.3245
淨資產收益率:-65.74%
總資產收益率:-30.16%
市淨率:4.43
市盈率(LYR):-6.64

資料載入中...

2023/08/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/17

重要事件披露

Form 8-K - Current report
2023/06/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

重要事件披露

8-K - Current report
2023/04/12

重要事件披露

8-K - Current report
2023/03/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/08

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals